Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Hawaii Biotech identified new botulinum neurotoxin inhibitors

Jan. 12, 2021

Viralym-M enters phase III for virus-associated hemorrhagic cystitis

Jan. 12, 2021

rVSV-deltaG-spike vaccine protects hamsters against SARS-CoV-2 challenge

Jan. 12, 2021

Tocilizumab to be used in U.K. for ICU patients with COVID-19

Jan. 11, 2021

Positive phase IIb data presented for DBI-001 in tinea pedis

Jan. 11, 2021

Inhaled phage therapy YPT-01 enters phase I/II trial to treat P. aeruginosa in cystic fibrosis

Jan. 11, 2021

JMX-0207 inhibits Zika virus both in vitro and in vivo

Jan. 11, 2021

LY-CoV555 does not show efficacy in hospitalized patients with COVID-19

Jan. 8, 2021

GlaxoSmithKline plc discloses new antibacterials

Jan. 8, 2021

Phase III ultraVIOLET study of oteseconazole for recurrent VVC meets endpoints

Jan. 7, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...